Latest Conference Articles

Personalized Medicine Vs. Precision Medicine

Personalized Medicine Vs. Precision Medicine

January 9th 2026

Dr. Jennifer Levin Carter, founder and CEO of Medzown, discusses what makes precision medicine different from personalized medicine and what how challenges faced in this evolving field can be overcome.

The Benefits of an Immune-Directed ADC Strategy

The Benefits of an Immune-Directed ADC Strategy

January 9th 2026

Arthur Tzianabos, CEO, Lifordi Immunotherapeutics, spoke with PharmTech about the company’s immune-directed antibody-drug conjugate (ADC) strategy, the benefits of VISTA-targeted ADCs in drug delivery, and Lifordi’s plans at the JP Morgan Healthcare Conference.

Gene Therapy, Rare Diseases, and Transfer RNA

Gene Therapy, Rare Diseases, and Transfer RNA

January 8th 2026

Elisabeth Gardiner, CSO of Tevard Biosciences, discusses how transfer RNA is impacting the development of gene therapies for diseases with unmet needs.

Medable Presents AI Agent for Automating Trial Master File Processes at JP Morgan Healthcare Conference

Medable Presents AI Agent for Automating Trial Master File Processes at JP Morgan Healthcare Conference

January 8th 2026

The company’s new AI agent automates labor-intensive processes involved in trial document management.

Tjoapack’s Advanced Packaging Expansion Aims to Meet  Rising Demand

Tjoapack’s Advanced Packaging Expansion Aims to Meet Rising Demand

December 11th 2025

A new facility in Tennessee will boost high-speed pharma packaging capacity and strengthen US supply chain support.

Sanner to Launch Tethered Cap at Pharmapack Europe 2026

Sanner to Launch Tethered Cap at Pharmapack Europe 2026

December 10th 2025

The new Tethered Cap, which will be showcased at 2026 Pharmapack Europe, addresses the demand for sustainability with a TE safety ring that remains attached to the cap.

Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two

Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two

November 19th 2025

AAPS

The conclusion of this interview with Sanjay Konagurthu focuses on simulations and calculations that go beyond simple screening.

Leveraging AI/ML to Reduce Risk in Drug Development: Part One

Leveraging AI/ML to Reduce Risk in Drug Development: Part One

November 18th 2025

AAPS

Sanjay Konagurthu of Thermo Fisher Scientific discusses how AI and ML can help solve the dilemma of poor solubility.

Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation

Shifting from Trial-and-Error to Rational Design Drives Efficiency in Pharmaceutical Formulation

November 17th 2025

AAPS

Mechanistic models and hypothesis-driven strategies generate optimized efficient solutions for drug development, says Catalent’s Nathan Bennette at AAPS PharmSci 360.

At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development

At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development

November 14th 2025

AAPS

Corey Bloom of Lonza outlines major points from his AAPS presentation, from drug delivery technology selection to the importance of CDMO partnerships.